G. Siebert

804 total citations
39 papers, 485 citations indexed

About

G. Siebert is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, G. Siebert has authored 39 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in G. Siebert's work include Drug Transport and Resistance Mechanisms (8 papers), Metabolism and Genetic Disorders (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). G. Siebert is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Metabolism and Genetic Disorders (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). G. Siebert collaborates with scholars based in Australia, Germany and United States. G. Siebert's co-authors include Michael S. Roberts, Daniel Y. Hung, George D. Mellick, H. Ritter, John F. Thompson, B. Mark Smithers, Peter A. Silburn, Yuri G. Anissimov, Greg T. Sutherland and Susan M. Pond and has published in prestigious journals such as Nature, British Journal of Cancer and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

G. Siebert

37 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Siebert Australia 14 186 129 91 66 54 39 485
Jeffrey L. Staecker United States 10 472 2.5× 89 0.7× 78 0.9× 62 0.9× 83 1.5× 10 829
Guadalupe Palencia Mexico 15 245 1.3× 113 0.9× 34 0.4× 76 1.2× 72 1.3× 26 711
F. Willig Germany 10 243 1.3× 60 0.5× 26 0.3× 48 0.7× 40 0.7× 27 476
Julius Halaschek-Wiener Canada 14 420 2.3× 155 1.2× 85 0.9× 21 0.3× 40 0.7× 15 832
Mitsue Miyazaki Japan 12 163 0.9× 78 0.6× 191 2.1× 118 1.8× 41 0.8× 27 588
Masaya Ikegawa Japan 16 408 2.2× 86 0.7× 67 0.7× 55 0.8× 71 1.3× 37 940
V. Suntzeff United States 13 378 2.0× 68 0.5× 59 0.6× 42 0.6× 25 0.5× 28 707
Piruz Nahreini United States 16 472 2.5× 91 0.7× 94 1.0× 54 0.8× 161 3.0× 35 890
Zhaoyu Qin China 16 393 2.1× 105 0.8× 56 0.6× 40 0.6× 38 0.7× 39 740
Mika Kawamura Japan 9 312 1.7× 133 1.0× 17 0.2× 50 0.8× 50 0.9× 10 542

Countries citing papers authored by G. Siebert

Since Specialization
Citations

This map shows the geographic impact of G. Siebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Siebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Siebert more than expected).

Fields of papers citing papers by G. Siebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Siebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Siebert. The network helps show where G. Siebert may publish in the future.

Co-authorship network of co-authors of G. Siebert

This figure shows the co-authorship network connecting the top 25 collaborators of G. Siebert. A scholar is included among the top collaborators of G. Siebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Siebert. G. Siebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutherland, Greg T., G. Siebert, Jillian J. Kril, & George D. Mellick. (2011). Knowing Me, Knowing You: Can a Knowledge of Risk Factors for Alzheimer's Disease Prove Useful in Understanding the Pathogenesis of Parkinson's Disease?. Journal of Alzheimer s Disease. 25(3). 395–415. 22 indexed citations
2.
Mellick, George D., Peter A. Silburn, Greg T. Sutherland, & G. Siebert. (2010). Exploiting the potential of molecular profiling in Parkinson’s disease: current practice and future probabilities. Expert Review of Molecular Diagnostics. 10(8). 1035–1050. 13 indexed citations
3.
Roberts, Michael S., Xin Liu, Yuhong Zou, et al.. (2010). Effect of adjuvant-induced systemic inflammation in rats on hepatic disposition kinetics of taurocholate. American Journal of Physiology-Gastrointestinal and Liver Physiology. 300(1). G130–G136. 5 indexed citations
4.
Sutherland, Greg T., G. Siebert, Jeremy R. B. Newman, et al.. (2009). Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease. Movement Disorders. 24(3). 448–452. 16 indexed citations
5.
Mellick, George D., G. Siebert, Manabu Funayama, et al.. (2008). Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia. Parkinsonism & Related Disorders. 15(2). 105–109. 48 indexed citations
6.
Hung, Daniel Y., et al.. (2005). Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver. British Journal of Pharmacology. 145(1). 57–65. 22 indexed citations
7.
Hung, Daniel Y., G. Siebert, M. W. Whitehouse, et al.. (2005). Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(2). G343–G351. 21 indexed citations
8.
Mills, P. C., G. Siebert, & Michael S. Roberts. (2004). A model to study intestinal and hepatic metabolism of propranolol in the dog. Journal of Veterinary Pharmacology and Therapeutics. 27(1). 45–48. 4 indexed citations
9.
Hung, Daniel Y., et al.. (2004). Disposition Kinetics of Propranolol Isomers in the Perfused Rat Liver. Journal of Pharmacology and Experimental Therapeutics. 311(2). 822–829. 9 indexed citations
10.
Siebert, G., et al.. (2004). Ion-Trapping, Microsomal Binding, and Unbound Drug Distribution in the Hepatic Retention of Basic Drugs. Journal of Pharmacology and Experimental Therapeutics. 308(1). 228–235. 58 indexed citations
11.
Hung, Daniel Y., Frank J. Burczynski, Andrew L. Lewis, et al.. (2003). Fatty acid binding protein is a major determinant of hepatic pharmacokinetics of palmitate and its metabolites. American Journal of Physiology-Gastrointestinal and Liver Physiology. 284(3). G423–G433. 15 indexed citations
12.
Roberts, Michael S., Zhen Wu, G. Siebert, et al.. (2001). Pharmacokinetics and pharmacodynamics of melphalan in isolated limb infusion for recurrent localized limb malignancy. Melanoma Research. 11(4). 423–431. 21 indexed citations
13.
Roberts, Michael S., et al.. (2001). Saturable dose–response relationships for melphalan in melanoma treatment by isolated limb infusion in the nude rat. Melanoma Research. 11(6). 611–618. 21 indexed citations
14.
Siebert, G., Susan M. Pond, & L. J. Bryan‐Lluka. (2000). Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 361(3). 255–264. 9 indexed citations
15.
Bryan‐Lluka, L. J., G. Siebert, & Susan M. Pond. (1999). Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 360(2). 109–115. 12 indexed citations
16.
Siebert, G. & António Amorim. (1987). Mitochondrial Malic Enzyme in Human Leukocytes. Human Heredity. 37(2). 122–123. 2 indexed citations
17.
Siebert, G., et al.. (1971). [Differentiation of two cathepsins from cod muscle].. PubMed. 352(6). 878–82.
18.
Siebert, G., et al.. (1964). Participation of Rat Liver Nuclei in Movements of Sodium. Nature. 204(4961). 888–888. 14 indexed citations
19.
Siebert, G., Gerhard Jung, & Karl S. Lang. (1955). [Intracellular distribution of acid phosphatase in bull prostate].. PubMed. 326(7). 464–8. 2 indexed citations
20.
Siebert, G.. (1954). [Growth and cell division].. PubMed. 9(4). 193–207. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey L. Staecker Breakdown of academic impact, for papers by Guadalupe Palencia Breakdown of academic impact, for papers by F. Willig Breakdown of academic impact, for papers by Julius Halaschek-Wiener Breakdown of academic impact, for papers by Mitsue Miyazaki Breakdown of academic impact, for papers by Masaya Ikegawa Breakdown of academic impact, for papers by V. Suntzeff Breakdown of academic impact, for papers by Piruz Nahreini Breakdown of academic impact, for papers by Zhaoyu Qin Breakdown of academic impact, for papers by Mika Kawamura
Rankless by CCL
2026